Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
Xiaofei ChenChun-Lin ZhuangYibin RenHao ZhangXia QinLongmiao HuJing FuZhenyuan MiaoYifeng ChaiZheng-Gang LiuHaibing ZhangZhenyu CaiHong-Yang WangPublished in: British journal of pharmacology (2019)
TAK-632 is an inhibitor of necroptosis and represents a new lead compound in the development of highly potent inhibitors of RIPK1 and RIPK3.
Keyphrases